Charles River Laboratories
CRL · Life Sciences Tools & Services
$345.37
1.7%Mettler Toledo
MTD · Life Sciences Tools & Services
$1,670.29
0.9%The short version
- Mettler Toledo is the larger business, with $4.0B of revenue in fiscal 2025 against $4.0B for Charles River Laboratories.
- Mettler Toledo grew revenue faster (4.0%, against −0.9%).
- Mettler Toledo turned more of its sales into free cash flow (21.1% FCF margin, against 12.9% FCF margin).
- Mettler Toledo earned a higher return on the capital invested in it (50.5%, against 0.4%).
| Latest fiscal year | CRL · FY25 | MTD · FY25 |
|---|---|---|
| Size | ||
| Market cap | $16.6B | $33.7B |
| Revenue | $4.0B | $4.0B |
| Free cash flow | $518M | $849M |
| Net income | −$144M | $869M |
| Growth | ||
| Revenue growth | −0.9% | 4.0% |
| 5-year growth | 6.6% | 5.5% |
| Share count change | −4.0% | −3.0% |
| Profitability | ||
| Gross margin | — | 59.4% |
| Operating margin | 0.6% | — |
| Net margin | −3.6% | 21.6% |
| FCF margin | 12.9% | 21.1% |
| Return on capital | 0.4% | 50.5% |
| Return on equity | −4.4% | — |
| Balance sheet | ||
| Net debt | $1.9B | $2.0B |
| Net debt / EBITDA | 4.5x | 1.7x |
| Dividends and buybacks | $361M | $800M |
| Valuation & quality | ||
| P/E | — | 37.6x |
| Piotroski F-score | 4 | 7 |
FY16
CRL $1.7B
MTD $2.5B
FY17
CRL $1.9B
MTD $2.7B
FY18
CRL $2.3B
MTD $2.9B
FY19
CRL $2.6B
MTD $3.0B
FY20
CRL $2.9B
MTD $3.1B
FY21
CRL $3.5B
MTD $3.7B
FY22
CRL $4.0B
MTD $3.9B
FY23
CRL $4.1B
MTD $3.8B
FY24
CRL $4.1B
MTD $3.9B
FY25
CRL $4.0B
MTD $4.0B
CRL
MTD
FY16
CRL 14.1%
MTD —
FY17
CRL 15.5%
MTD —
FY18
CRL 14.6%
MTD —
FY19
CRL 13.4%
MTD —
FY20
CRL 14.8%
MTD —
FY21
CRL 16.7%
MTD —
FY22
CRL 16.4%
MTD —
FY23
CRL 15.0%
MTD —
FY24
CRL 5.6%
MTD —
FY25
CRL 0.6%
MTD —
CRL
MTD
FY16
CRL $262M
MTD $337M
FY17
CRL $236M
MTD $389M
FY18
CRL $301M
MTD $422M
FY19
CRL $340M
MTD $506M
FY20
CRL $380M
MTD $632M
FY21
CRL $532M
MTD $801M
FY22
CRL $295M
MTD $738M
FY23
CRL $365M
MTD $861M
FY24
CRL $502M
MTD $864M
FY25
CRL $518M
MTD $849M
CRL
MTD
FY16
CRL 10.1%
MTD 36.8%
FY17
CRL 7.5%
MTD 31.7%
FY18
CRL 11.4%
MTD 39.2%
FY19
CRL 9.8%
MTD 41.6%
FY20
CRL 9.9%
MTD 43.4%
FY21
CRL 11.1%
MTD 51.4%
FY22
CRL 9.9%
MTD 52.6%
FY23
CRL 8.9%
MTD 48.6%
FY24
CRL 2.0%
MTD 55.7%
FY25
CRL 0.4%
MTD 50.5%
CRL
MTD
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.